Article
Precision medicine at the crossroads.
Human genomics - 11 Oct 2017
Olson Maynard V
Abstract excerpt
There are bioethical, institutional, economic, legal, and cultural obstacles to creating the robust-precompetitive-data resource that will be required to advance the vision of "precision medicine," the ability to use molecular data to target therapies to patients for whom they offer the most benefit at the least risk. Creation of such an "information commons" was the central recommendation of the 2011 report...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
